TrialGynecologic oncology2012

A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma.

Andrea E Wahner Hendrickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.